Volume 69, Issue 1, Pages (July 2018)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 67, Issue 3, Pages (September 2017)
Volume 63, Issue 1, Pages (July 2015)
Volume 53, Issue 1, Pages (July 2010)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis  Wichit Srikureja,
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Non-invasive diagnosis of non-alcoholic fatty liver disease
Immigration and viral hepatitis
Marcus-Alexander Wörns, Peter Robert Galle  Journal of Hepatology 
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
European Association for the Study of the Liver  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
The place of downstaging for hepatocellular carcinoma
Autoimmune hepatitis: A life-long disease
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 70, Issue 1, Pages (January 2019)
Trends in the management and burden of alcoholic liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 58, Issue 3, Pages (March 2013)
Volume 62, Issue 3, Pages (March 2015)
Management of cirrhosis due to chronic hepatitis C
Genomic risk of hepatitis C-related hepatocellular carcinoma
Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away?
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 69, Issue 3, Pages (September 2018)
Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual 
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 65, Issue 2, Pages (August 2016)
EASL Clinical Practice Guidelines on hepatitis E virus infection
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Chronic hepatitis B in children and adolescents
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
MELD: the holy grail of organ allocation?
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 69, Issue 1, Pages 154-181 (July 2018) EASL Clinical Practice Guidelines: Management of alcohol-related liver disease  Mark Thursz, Antoni Gual, Caroline Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck, Helena Cortez- Pinto Mark Thursz, Antoni Gual, Caroline Lackner, Philippe Mathurin, Christophe Moreno, Laurent Spahr, Martina Sterneck, Helena Cortez-Pinto  Journal of Hepatology  Volume 69, Issue 1, Pages 154-181 (July 2018) DOI: 10.1016/j.jhep.2018.03.018 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Treatment algorithm in patients with suspected alcoholic hepatitis. *Particularly in null responders (Lille score ≥0.56). AH, alcoholic hepatitis; BW, bodyweight; DILI, drug-induced liver injury; GAHS, Glasgow alcoholic hepatitis score; mDF, maddrey discriminant function. Journal of Hepatology 2018 69, 154-181DOI: (10.1016/j.jhep.2018.03.018) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 2 The trend in aetiologies of cirrhosis leading to liver transplantation in Europe. Journal of Hepatology 2018 69, 154-181DOI: (10.1016/j.jhep.2018.03.018) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions